Kelly Coffey

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Venues

Communications biology

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Rebecca Garnham, Daniel Geh, Ryan Nelson, Erik Ramon-Gil, Laura Wilson, Edward N Schmidt, Laura Walker, Beth Adamson, Adriana Buskin, Anastasia C Hepburn, Kirsty Hodgson, Hannah Kendall, Fiona M Frame, Norman Maitland, Kelly Coffey, Douglas W Strand, Craig N Robson, David J Elliott, Rakesh Heer, Matthew Scott Macauley, Jennifer Munkley, Luke Gaughan, Jack Leslie, Emma Scott
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer. Communications biology 7 (1) (2024)
Rebecca Garnham, Daniel Geh, Ryan Nelson, Erik Ramon-Gil, Laura Wilson, Edward N Schmidt, Laura Walker, Beth Adamson, Adriana Buskin, Anastasia C Hepburn, Kirsty Hodgson, Hannah Kendall, Fiona M Frame, Norman Maitland, Kelly Coffey, Douglas W Strand, Craig N Robson, David J Elliott, Rakesh Heer, Matthew Scott Macauley, Jennifer Munkley, Luke Gaughan, Jack Leslie, Emma Scott
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer. Communications biology 7 (1) (2024)
Emma Lishman-Walker, Kelly Coffey
Casein Kinase 1α-A Target for Prostate Cancer Therapy? Cancers 16 (13) (2024)
Rebecca Garnham, Daniel Geh, Ryan Nelson, Erik Ramon-Gil, Laura Wilson, Edward N Schmidt, Laura Walker, Beth Adamson, Adriana Buskin, Anastasia C Hepburn, Kirsty Hodgson, Hannah Kendall, Fiona M Frame, Norman Maitland, Kelly Coffey, Douglas W Strand, Craig N Robson, David J Elliott, Rakesh Heer, Matthew Scott Macauley, Jennifer Munkley, Luke Gaughan, Jack Leslie, Emma Scott
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer. Communications biology 7 (1) (2024)
Rebecca Garnham, Daniel Geh, Ryan Nelson, Erik Ramon-Gil, Laura Wilson, Edward N Schmidt, Laura Walker, Beth Adamson, Adriana Buskin, Anastasia C Hepburn, Kirsty Hodgson, Hannah Kendall, Fiona M Frame, Norman Maitland, Kelly Coffey, Douglas W Strand, Craig N Robson, David J Elliott, Rakesh Heer, Matthew Scott Macauley, Jennifer Munkley, Luke Gaughan, Jack Leslie, Emma Scott
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer. Communications biology 7 (1) (2024)
Emma Lishman-Walker, Kelly Coffey
Casein Kinase 1α-A Target for Prostate Cancer Therapy? Cancers 16 (13) (2024)
Zainab A H Alebady, Mahsa Azizyan, Sirintra Nakjang, Emma Lishman-Walker, Dhuha Al-Kharaif, Scott Walker, Hui Xian Choo, Rebecca Garnham, Emma Scott, Katya L Johnson, Craig N Robson, Kelly Coffey
CDC20 Is Regulated by the Histone Methyltransferase, KMT5A, in Castration-Resistant Prostate Cancer. Cancers 15 (14) (2023)

Kelly Coffey.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kelly Coffey